OOIR: Observatory of International Research

Papers

(The H4-Index of Radiotherapy and Oncology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Contents	154
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration	121
529 Current standard of care treatment in non-metastatic cervix cancer	111
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation	93
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials	93
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy	84
Response to the commentary on “Optimizing fractionation schedules for de-escalation radiotherapy in head and neck cancers using deep reinforcement learning” by Mohammad Zahid, and Heiko Enderling	81
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)	75
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans	75
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs	73
525 Proton and carbon therapy: recent technological advances	71
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial	70
45 Stereotactic radiosurgery for tremor: a center experience.	69
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone	67
Corrigendum to “Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing” [Radiother. Oncol. 200 (2024) 110477]	65
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer	63
157 Adaptive radiation therapy	62
480 Addressing the education and training needs of RTT in particle radiation therapy	61
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	58
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	55
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy	55
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome	54
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	53
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study	52
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	51

3429: Modulating innate immunity by DNA damage response inhibition	50
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	50
749: Reinforcement learning for accelerated automatic treatment planning optimization	49
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	49
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	48
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer	48
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	48
1635: In vivo dosimetry - keeping my finger on the pulse	47
1861: Performance of a heart substructures autocontouring tool after clinical implementation	45
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	45
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT	45
3201: Dosimetric properties of flexible 3D-printed boluses	44
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife	44
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility	43
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	43
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer	42
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	42